← Back
$AXSM All transactions

Axsome Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$2.4M

Shares

20,000

Price

$122

Filed

Aug 29

Insider

Name

JEFFS ROGER

Title

CIK

0001231615

Roles

Director

Transaction Details

Transaction Date

2025-08-27

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

110,974

Footnotes

Represents the sale of underlying shares of previously exercised stock options. | Such transaction was pursuant to a pre-approved 10b5-1 plan. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.74 and $123.56. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.75 and $122.47. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.02 and $122.28.

Filing Info

Accession No.

0001231615-25-000006

Form Type

4

Issuer CIK

0001579428

JEFFS ROGER's History

Date Ticker Type Value
2026-04-17 LQDA $765K
2026-04-16 LQDA $1.0M
2026-04-15 LQDA $1.0M
2026-04-14 LQDA $132K
2026-04-13 LQDA $1.3M
2026-04-10 LQDA M
2026-04-10 LQDA M
2026-04-10 LQDA $860K
2026-04-10 LQDA M $0
2026-04-10 LQDA M $0

Other Insiders at AXSM (90d)

Insider Bought Sold Last
TABUTEAU HERRIOT
Chief Executive Officer
$6.0M 2026-04-21
Coleman Mark $4.0M 2026-02-26
Pizzie Nick
Chief Financial Officer
2026-04-21
Jacobson Mark L.
Chief Operating Officer
$5.7M 2026-04-21
Murdock Hunter R.
General Counsel
2026-04-21
Maizel Ari
Chief Commercial Officer
$1.4M 2026-04-22